AtriCure (ATRC) Gains from Investment Securities (2010 - 2026)
AtriCure (ATRC) reported Gains from Investment Securities of $11.4 million for Q1 2026, up 12.49% year-over-year from $10.2 million in Q1 2025, and up 20.03% quarter-over-quarter from $9.5 million in Q4 2025.
AtriCure (ATRC) Gains from Investment Securities (2010 - 2026) Analysis & Trends
AtriCure (ATRC) has 17 years of Gains from Investment Securities data on file, last reported at $11.4 million in Q1 2026.
- Gains from Investment Securities for Q1 2026 came in at $11.4 million, up 12.49% year-over-year; the trailing twelve-month figure through Mar 2026 was $12.4 million (up 192.27% YoY), and the FY2025 annual result was $11.2 million, up 1703.39% from the prior year.
- Gains from Investment Securities rose to $11.4 million in Q1 2026 per ATRC's latest filing, from $9.5 million in the prior quarter.
- Over five years, Gains from Investment Securities peaked at $11.4 million in Q1 2026 and troughed at -$11.9 million in Q4 2022.
- A 5-year average of $1.8 million and a median of $459500.0 in 2023 frame the typical range for Gains from Investment Securities.
- The sharpest annual moves came in 2022 and 2024: Gains from Investment Securities plunged 10860.36% in 2022, then soared 54575.0% in 2024.
- A 5-year view of Gains from Investment Securities shows it stood at -$11.9 million in 2022, then soared by 100.7% to $84000.0 in 2023, then tumbled by 7409.52% to -$6.1 million in 2024, then surged by 255.26% to $9.5 million in 2025, then advanced by 20.03% to $11.4 million in 2026.
- Business Quant data shows ATRC's Gains from Investment Securities at $11.4 million in Q1 2026, $9.5 million in Q4 2025, and $748000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Intuitive Surgical | 148.09 Bn | 143.69 Bn | 1.83 Bn |
| 2 | Becton Dickinson | 41.00 Bn | 39.99 Bn | 2.15 Bn |
| 3 | Medline | 30.38 Bn | 36.22 Bn | 1.84 Bn |
| 4 | Resmed | 28.22 Bn | 26.56 Bn | 890.98 Mn |
| 5 | West Pharmaceutical Services | 23.72 Bn | 23.19 Bn | 296.40 Mn |
| 6 | Solventum | 13.33 Bn | 13.33 Bn | 1.10 Bn |
| 7 | Cooper Companies | 13.12 Bn | 12.99 Bn | 735.40 Mn |
| 8 | Align Technology | 12.86 Bn | 11.80 Bn | 736.59 Mn |
| 9 | Baxter International | 10.51 Bn | 8.47 Bn | 891.00 Mn |
| 10 | AtriCure | 1.34 Bn | 1.19 Bn | 109.31 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 11.44 Mn |
| Mar 31, 2026 | 11.44 Mn |
| Dec 31, 2025 | 9.53 Mn |
| Dec 31, 2025 | 9.53 Mn |
| Sep 30, 2025 | 748,000.00 |
| Sep 30, 2025 | 748,000.00 |
| Jun 30, 2025 | -9.29 Mn |
| Jun 30, 2025 | -9.29 Mn |
| Mar 31, 2025 | 10.17 Mn |
| Mar 31, 2025 | 10.17 Mn |
| Dec 31, 2024 | -6.14 Mn |
| Dec 31, 2024 | -6.14 Mn |
| Sep 30, 2024 | 63,000.00 |
| Sep 30, 2024 | 63,000.00 |
| Jun 30, 2024 | 159,000.00 |
| Jun 30, 2024 | 159,000.00 |
| Mar 31, 2024 | 6.54 Mn |
| Mar 31, 2024 | 6.54 Mn |
| Dec 31, 2023 | 84,000.00 |
| Dec 31, 2023 | 84,000.00 |